The osteoporosis test is a type of procedure that allows doctors / rheumatologists to examine bone density in the outpatient clinic. Osteoporosis is a disease identified by thinning and deterioration of bone tissue with loss of calcification and density. Osteoporosis may increase over time. This can make the bone fragile and increasingly porous. Women and the elderly are more at risk of suffering from osteoporosis. Inheritance, low body weight and chronic use of certain drugs (steroids) may also be risk factors for the disease. Lifting, bending, bumping, sneezing can also cause a bone to break in people with osteoporosis. The osteoporosis test helps estimate bone density and bone breakage probabilities. Osteoporosis tests monitor bone density, doctors usually refer to the bone densitometer. Bone loss can occur due to various ailments, including rheumatoid arthritis, hyperparathyroidism, chronic kidney disease, multiple myeloma or drugs such as antiepileptics and glucocorticoids.
Osteoporosis test market: drivers and restrictions
The growing incidence of osteoporosis is driving the growth of the osteoporosis test market. Fast turnaround times, lower processing costs compared to conventional methods also fuel the growth of the osteoporosis test market. Furthermore, the varied application of osteoporosis test procedures in analyzing / localizing bone density and increasing adoption into a routine osteoporosis check is exploiting the growth of the test market. osteoporosis. The osteoporosis test is the technological integration of the existing bone densitometer or the scanning techniques have further reduced the risk associated with kyphoplasty or vertebroplasty procedures. However, the potential side effects associated with kyphoplasty or vertebroplasty procedures such as epistaxis, fainting, fluctuation in blood pressure or reactions due to anesthesia would hinder the rate of adoption. The lack of awareness of joint pain and osteoporosis and limitations of DEXA leads to limit the market for osteoporosis tests.
Request a free sample report @ www.factmr.com/connectus/sample?flag=S&rep_id=1219
Osteoporosis test market: segmentation
The market for osteoporosis tests has been segmented based on the component, end user and geography.
Depending on the type of product, the osteoporosis test market is segmented as follows:
Based on the end user, the market for osteoporosis testing is segmented as follows:
Outpatient surgical centers
Osteoporosis test market: overview
According to the International Osteoporosis Foundation, worldwide, 8.9 million people suffer fractures every year due to osteoporosis. About one-tenth of the 60-year-olds, one fifth of 70-year-old women, two-fifths of 80-year-old women and two-thirds of 90-year-old women. Osteoporosis affects about 75 million people in Europe, North America and Japan. A growing number of patients have visited osteoporosis tests and its growing demand shows lucrative growth opportunities for companies investing in this market.
Request / View TOC @ www.factmr.com/connectus/sample?flag=T&rep_id=1219
Osteoporosis test market: Regional Outlook
From the geographical point of view, the test market for osteoporosis is segmented into regions. North America, Europe, Asia-Pacific excluding Japan, the Middle East and Africa and Japan. The region of North America and Europe shows healthy growth in terms of revenue due to greater awareness of osteoporosis control as part of routine control. The lower cost of the procedure compared to other alternative treatments and low risk associated with the procedure is increasing the growth of the osteoporosis test market. The developing cluster of North America, Asia and Africa is likely to gain momentum towards the end of 2020. The population of patients suffering from osteoporosis testing is mainly prescribed with a alternative medicine treatment in the region, which results in chronic side effects due to treatment.
Osteoporosis test market: key players
Some of the players identified in the osteoporosis testing market include GE Healthcare, Merck & Company, B.M.Tech. Worldwide Co. Ltd, DMS Imaging, Swissray, Hologic Inc. Pfizer Inc., CompuMed, Inc., Eli Lilly and Company
The report is a collection of first-hand information, a qualitative and quantitative assessment by industry analysts, contributions from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parental market trends, macroeconomic indicators and government factors, as well as market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographical areas.
The report covers a comprehensive analysis on:
Supply and demand
Current trends / problems / challenges
Competition and companies involved
The regional analysis includes
North America (United States, Canada)
Latin America (Argentina, Mexico, Brazil)
Europe (Germany, Italy, United Kingdom, Spain, France, Russia, Poland)
Asia Pacific Excluding Japan (India, Australia and New Zealand, China, ASEAN)
Middle East and Africa (GCC, South Africa, Rest Of MEA)
Highlights of the report:
Detailed overview of the parental market
Change in market dynamics in the sector
In-depth market segmentation
Size of the historical market, current and prospective in terms of volume and value
Trends and recent developments in the sector
Key player strategies and products offered
Potential and niche segments, geographic regions showing promising growth
A neutral perspective on market trends
Essential information for market operators to support and improve their impact on the market.
Report Analysis @ www.factmr.com/report/1219/osteoporosis-testing-market
Fact.MR is a rapidly growing market research company that offers the most complete suite of syndicated and customized market research reports. We believe that transformative intelligence can educate and inspire companies to make smarter decisions. We know the limits of the one-size-fits-all approach; this is why we publish global, regional and country-specific multinational research reports.
11140 Rockville Pike
Rockville, MD 20852
Read industry news on – theguardiantribune.com
This version was published on openPR.